Alloy Therapeutics: Funding, Investors & Team (Oct 2026)
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts.
Alloy Therapeutics has raised $157M across 3 funding rounds on record, the most recent a Series E of $40.0M announced in Apr 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alloy Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Alloy Therapeutics Funding Rounds
Alloy Therapeutics raised $75.0M in a Series C announced in Apr 2021.
1.5 years later, a Series D of $42.0M was announced in Oct 2022.
3.5 years later, a Series E of $40.0M was announced in Apr 2026.
Alloy Therapeutics Founders and Leadership Team
Contact details for the Alloy Therapeutics team: 2 of 3 have an email address on file.
Start 14-day free trial →Alloy Therapeutics Funding Compared to Other Biotechnology Startups
Alloy Therapeutics' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alloy Therapeutics in Biotechnology and Lexington
Companies Similar to Alloy Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Alloy Therapeutics Funding FAQs
What does Alloy Therapeutics do?
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts.
How much funding has Alloy Therapeutics raised?
Alloy Therapeutics has raised $157M across 3 rounds on record. The most recent is a Series E of $40.0M announced in Apr 2026.
When did Alloy Therapeutics last raise funding?
Alloy Therapeutics' most recent funding round on record is a Series E of $40.0M, announced in Apr 2026.
Who founded Alloy Therapeutics?
FundedIQ lists Christian Cobaugh (Founder) at Alloy Therapeutics.
Who is the CEO of Alloy Therapeutics?
Dongxing Zha is listed as CEO at Alloy Therapeutics.
Where is Alloy Therapeutics headquartered?
Alloy Therapeutics is based in Lexington, Massachusetts, United States.
How many employees does Alloy Therapeutics have?
Alloy Therapeutics is in the 101-250 employee band.
How does Alloy Therapeutics' funding compare to other Biotechnology startups?
Alloy Therapeutics' latest round of $40.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Alloy Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alloy Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.